Ethic Inc’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Sell |
18,490
-1,399
| -7% | -$23.4K | 0.01% | 973 |
|
|
2025
Q1 | $304K | Sell |
19,889
-35,434
| -64% | -$542K | 0.01% | 931 |
|
|
2024
Q4 | $1.22M | Buy |
55,323
+17,267
| +45% | +$381K | 0.02% | 545 |
|
|
2024
Q3 | $635K | Sell |
38,056
-6,320
| -14% | -$106K | 0.02% | 706 |
|
|
2024
Q2 | $721K | Buy |
44,376
+4,397
| +11% | +$71.5K | 0.02% | 661 |
|
|
2024
Q1 | $564K | Buy |
39,979
+28,748
| +256% | +$406K | 0.01% | 731 |
|
|
2023
Q4 | $117K | Sell |
11,231
-176
| -2% | -$1.84K | ﹤0.01% | 1014 |
|
|
2023
Q3 | $116K | Buy |
+11,407
| New | +$116K | ﹤0.01% | 975 |
|
|
2023
Q2 | – | Sell |
-14,446
| Closed | -$128K | – | 1016 |
|
|
2023
Q1 | $128K | Buy |
+14,446
| New | +$128K | 0.01% | 916 |
|
|
2022
Q4 | – | Sell |
-13,392
| Closed | -$108K | – | 930 |
|
|
2022
Q3 | $108K | Buy |
+13,392
| New | +$108K | 0.01% | 764 |
|